191 related articles for article (PubMed ID: 6371237)
21. A nonspecific inhibitor of macrophage migration in cell-free ascites of rat Zajdela hepatoma. II. Biochemical characterization and purificaton.
Fahlbusch B; Zschiesche W
Acta Biol Med Ger; 1981; 40(6):793-800. PubMed ID: 7034428
[TBL] [Abstract][Full Text] [Related]
22. Studies on guinea-pig macrophage migration inhibitory factor (MIF). I. Glycoprotein nature and net charge.
Kotkes P; Pick E
Clin Exp Immunol; 1979 Sep; 37(3):532-9. PubMed ID: 228883
[TBL] [Abstract][Full Text] [Related]
23. [Stimulation of phagocytic function by factors inhibiting leukocyte and macrophage migration in humans].
Gankovskaia LV; Tskhovrebova AZ; Gvozdeva NA; Koval'chuk LV; Cheredeev AN
Biull Eksp Biol Med; 1986 Aug; 102(8):210-3. PubMed ID: 3527300
[TBL] [Abstract][Full Text] [Related]
24. The production of anti-guinea pig lymphokine antibody.
Yoshida T; Bigazzi PE; Cohen S
J Immunol; 1975 Feb; 114(2 Pt 1):688-91. PubMed ID: 1091701
[TBL] [Abstract][Full Text] [Related]
25. Mechanism of lymphocyte activation. II. Requirements for macromolecular synthesis in the production of lymphokines.
Varesio L; Holden HT; Taramelli D
J Immunol; 1980 Dec; 125(6):2810-7. PubMed ID: 6159423
[TBL] [Abstract][Full Text] [Related]
26. Partial characterization of murine migration inhibitory factor (MIF).
Kühner AL; David JR
J Immunol; 1976 Jan; 116(1):140-5. PubMed ID: 1107423
[TBL] [Abstract][Full Text] [Related]
27. Constitutive production of a non-interferon macrophage activating factor by HTLV-transformed T cells.
Lee JC
Lymphokine Res; 1986; 5 Suppl 1():S127-32. PubMed ID: 3023762
[TBL] [Abstract][Full Text] [Related]
28. Partial purification and physicochemical properties of human T cell migration inhibitory factor (TIF).
Kowalczyk D; Staykowa M; Litwora E; Pryjma J; Zembala M
J Clin Lab Immunol; 1984 Oct; 15(2):105-10. PubMed ID: 6394762
[TBL] [Abstract][Full Text] [Related]
29. Production and utilization of human lymphokines containing macrophage-activating factor (MAF) activity.
Kleinerman ES; Fidler IJ
Lymphokine Res; 1983; 2(1):7-12. PubMed ID: 6381900
[No Abstract] [Full Text] [Related]
30. Human polymorphonuclear leucocyte migration inhibitory factor. Evidence for antigen dependency.
Weisbart RH; Isaacson J; Bluestone R; Goldberg LS
Immunology; 1975 Aug; 29(2):223-30. PubMed ID: 50998
[TBL] [Abstract][Full Text] [Related]
31. Biochemical and functional characterisation of macrophage stimulating factors secreted by mitogen-induced goldfish kidney leucocytes.
Neumann NF; Stafford JL; Belosevic M
Fish Shellfish Immunol; 2000 Feb; 10(2):167-86. PubMed ID: 10938732
[TBL] [Abstract][Full Text] [Related]
32. Purification and biochemical characterization of human lymphocyte mitogenic factor (LMF).
Rutenberg WD; al-Khalidi U; Rosen FS; Merler E
J Immunol; 1979 Feb; 122(2):723-7. PubMed ID: 310850
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
Fahlbusch B; Tittel R
Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
[TBL] [Abstract][Full Text] [Related]
34. The production of a macrophage-activating factor from rainbow trout Salmo gairdneri leucocytes.
Graham S; Secombes CJ
Immunology; 1988 Oct; 65(2):293-7. PubMed ID: 3056854
[TBL] [Abstract][Full Text] [Related]
35. Partial purification of the cholestatic factor derived from the lymphocytes of tuberculin-sensitized guinea pigs.
Mizoguchi Y; Ohnishi F; Monna T; Yamamoto S; Morisawa S
Gastroenterol Jpn; 1981; 16(3):260-7. PubMed ID: 7021301
[TBL] [Abstract][Full Text] [Related]
36. Studies on the production of MIF and mitogenic factor using highly purified human T and B lymphocytes.
Rocklin RE; Chess L; MacDermott RP; Schlossman SF; David JR
Rheumatology; 1975; 6():98-105. PubMed ID: 1105751
[TBL] [Abstract][Full Text] [Related]
37. Macrophage-activating factor for cytotoxicity produced by a human T-cell hybridoma.
Higuchi M; Nakamura N; Tsuchiya SI; Kobayashi Y; Osawa T
Cell Immunol; 1984 Sep; 87(2):626-36. PubMed ID: 6205774
[TBL] [Abstract][Full Text] [Related]
38. Synergism between lymphokines and muramyl dipeptide encapsulated in liposomes: in situ activation of macrophages and therapy of spontaneous cancer metastases.
Fidler IJ; Schroit AJ
J Immunol; 1984 Jul; 133(1):515-8. PubMed ID: 6373933
[TBL] [Abstract][Full Text] [Related]
39. Production of migration inhibition factor (MIF) by purified human T cell subpopulations.
Warrington RJ; Olivier SL; Sauder PJ; Rutherford WJ
Clin Exp Immunol; 1981 May; 44(2):324-31. PubMed ID: 6458429
[TBL] [Abstract][Full Text] [Related]
40. Human leukocyte inhibitory factor (LIF): two distinct molecular species.
Brown AP; Rocklin RE
J Immunol; 1979 Mar; 122(3):1059-61. PubMed ID: 36430
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
